session 5

112
Session 5

Upload: wren

Post on 18-Jan-2016

18 views

Category:

Documents


0 download

DESCRIPTION

Session 5. Case. Diagnosis - Sclerosing adenosis with lobular neoplasia. No invasion in images provided. Update - Risk with LISN. Meta-analysis 9 studies of 228 patients 15% ipsilateral, 9% contralateral carcinoma Ipsilateral 3x more likely than contralateral. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Session 5

Session 5

Page 2: Session 5

Case

Page 3: Session 5
Page 4: Session 5
Page 5: Session 5
Page 6: Session 5
Page 7: Session 5
Page 8: Session 5
Page 9: Session 5
Page 10: Session 5
Page 11: Session 5
Page 12: Session 5
Page 13: Session 5
Page 14: Session 5

Diagnosis - Sclerosing adenosis with

lobular neoplasia.

No invasion in images provided.

Page 15: Session 5
Page 16: Session 5
Page 17: Session 5

Update - Risk with LISN

Meta-analysis 9 studies of 228 patients

15% ipsilateral, 9% contralateral carcinoma

Ipsilateral 3x more likely than contralateral

• A “model of premalignancy for ALH intermediate between a local precursor and a generalised risk for both breasts”

Page DL. Lancet. 2003;361:125-9

Page 18: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Is there a sub-group of pre-invasive LCIS? LCIS with Microinvasion

6 LCIS with microinvasion described

Nemoto T et al. J Surg Oncol 1998; 67; 41-46

Page 19: Session 5

Case 19

Page 20: Session 5
Page 21: Session 5
Page 22: Session 5
Page 23: Session 5
Page 24: Session 5
Page 25: Session 5
Page 26: Session 5
Page 27: Session 5
Page 28: Session 5
Page 29: Session 5
Page 30: Session 5

Diagnosis - Fibrocystic change with

papillomas and florid usual epithelial hyperplasia

Page 31: Session 5

Case 32

Page 32: Session 5
Page 33: Session 5
Page 34: Session 5
Page 35: Session 5
Page 36: Session 5
Page 37: Session 5
Page 38: Session 5
Page 39: Session 5
Page 40: Session 5
Page 41: Session 5
Page 42: Session 5
Page 43: Session 5
Page 44: Session 5
Page 45: Session 5
Page 46: Session 5

Diagnosis - Fibrocystic change with

atypical lobular hyperplasia and flat high grade DCIS

Page 47: Session 5

Case 54

Page 48: Session 5
Page 49: Session 5
Page 50: Session 5
Page 51: Session 5
Page 52: Session 5
Page 53: Session 5
Page 54: Session 5

Diagnosis - Radial scar with florid usual

epithelial hyperplasia

Page 55: Session 5

• Central fibro-elastosis with entrapped tubular structures

• Usual epithelial hyperplasia

• Helpful features – retraction around tubular structures – often seen in radial scars

• Lack of fibroblastic stromal reaction (commonly, but not invariably seen (!) in tubular carcinoma)

• Confirm presence of myoepithelial cells and exclude diagnosis of tubular carcinoma (e.g. with smooth muscle myosin or smooth muscle actin or p63)

• In the epithelial proliferation look for (a) mixed population, (b) streaming and (c) slit-like peripheral spaces

Radial Scar

Page 56: Session 5
Page 57: Session 5
Page 58: Session 5
Page 59: Session 5
Page 60: Session 5
Page 61: Session 5
Page 62: Session 5

Case 44

Page 63: Session 5
Page 64: Session 5
Page 65: Session 5
Page 66: Session 5
Page 67: Session 5
Page 68: Session 5
Page 69: Session 5

Diagnosis - High grade DCIS with comedo-

type necrosis and cancerisation of lobules.

No invasion or microinvasion.

Page 70: Session 5

MicroinvasionMicroinvasion• DCIS with a focus of invasion less than 1mm in

max. dimension• More than one focus, if each less than 1mm

Individual deposits may vary in size from a few islands to 1 mm diameter

• In the non-specialised, interlobular or inter-ductal connective tissue - neoplastic islands definitely within interlobular fibrous or adipose tissue

Excludes:Ultrastructural or immunocytochemical evidence of

breached or discontinuous basement membrane"Cancerisation of lobules"

Page 71: Session 5

Microinvasion

Observations

• Associated with high-grade comedo DCIS more than other types

• Increasing risk of axillary node involvement with increasing duct space involvement (>50 ducts)

Page 72: Session 5

Microinvasion

Problems of interpretation

• Duct boundary poorly defined

• Periductal fibrosis

• Indistinct basement membrane zone

• Tangential cutting of involved duct/lobule

Page 73: Session 5

Microinvasion

Tips

• Outside organoid structures

• Involves non-specialised stroma

• Host lymphocytic response

• No myoepithelial component

Page 74: Session 5

Microinvasion

Key points

• Restrictive definition

• Rare

• Axillary node involvement low

• Prognosis very good

Page 75: Session 5
Page 76: Session 5
Page 77: Session 5
Page 78: Session 5
Page 79: Session 5

Case 11a

Page 80: Session 5
Page 81: Session 5
Page 82: Session 5
Page 83: Session 5
Page 84: Session 5
Page 85: Session 5
Page 86: Session 5
Page 87: Session 5
Page 88: Session 5
Page 89: Session 5

Diagnosis -Medullary-like carcinoma

Page 90: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

CASE ?

• 36 year old patient

• Mastectomy and ALND post chemotherapy

• 5 months previously had core from 41mm mobile hypoechoic mobile mass in RUOQ

Page 91: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 92: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 93: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Core Biopsy• B5, invasive carcinoma of provisional (core)

grade 3 (333) and no special type

• ER = 6/8

• PGR = 0/8

• HER2 = negative (score 0)

Page 94: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 95: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 96: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 97: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 98: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 99: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 100: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 101: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 102: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 103: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 104: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 105: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Diagnosis

Residual carcinoma cells mimicking histiocytes

Page 106: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

• Central fibrotic scarring usually seen

• Patchy chronic inflammation within and around fibrosis

• Oedema or mucinous or myxoid changes to stroma or even areas of necrosis

• Cancer cells may mimic histiocytes, and vice versa, but collections of macrophages may also be present

• Cytokeratin IHC invaluable

Post-Chemotherapy Changes

Page 107: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 108: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 109: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 110: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Grade 1 Some alteration to individual cells but no overall reduction in numbers compared to pre-treatment core

Grade 2 Mild loss of invasive cells, still high cellularityGrade 3 Considerable reduction, up to 90% lossGrade 4 Marked reduction - only small clusters of

widely dispersed cells detectedGrade 5 No invasive carcinoma, in situ carcinoma or

tumour stroma may still be noted

Bonadonna G et al. J Natl Cancer Inst. 1990 3;82:1539-45Smith IC et al. J Clin Oncol 2002;20:1456-66

Response to Chemotherapy

Page 111: Session 5

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Response to Chemotherapy

1. Disappearance of all tumour

2. Presence of in situ carcinoma but no residual invasive tumour & no metastatic carcinoma found in the lymph nodes

3. Invasive carcinoma present with stromal changes, such as sclerosis or fibrosis

4. Few modifications of appearance of tumour

Chevallier B et al. Am J Clin Oncol 1993;16:223–228

Page 112: Session 5